Augmentive
PrivateLast Round
Seed
Mar 26, 2024
Company Overview
Augmentive operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in March 2024.
Augmentive is a digital health company that provides an online platform connecting individuals with mental health specialists, including psychiatrists, therapists, and coaches.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement
Business Model
B2C
Customer Profile
Marketplace Commission, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Augmentive Comparables
Compare Augmentive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProblemShared | 79% | |
| Centre for ADHD Research & Excellence | 76% | |
| Psychiatry-UK | 74% |
For institutional investors. Book with your work email.
Augmentive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 26, 2024 | ||||
| Seed | Apr 28, 2023 | ||||
| Seed | Jun 13, 2022 | ||||
| Seed | Apr 23, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Augmentive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venrex Investment Management | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Grew 16% QoQ, from 31 to 36 employees.
- Jan 4, 2026
Grew 17% QoQ, from 29 to 34 employees.
For institutional investors. Book with your work email.
Augmentive Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Augmentive's valuation, stock price, and market status.
Is Augmentive a public or private company?
Augmentive is a private company.
What is the current stock price of Augmentive?
Augmentive is a private company, so its shares have no public market price. Caplight tracks Augmentive's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Augmentive worth (valuation)?
Valuation information for Augmentive is not publicly available.
Can I buy Augmentive stock?
Augmentive shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Augmentive's last funding round?
Augmentive's most recent funding round was Seed on March 26, 2024.
Who are the main investors in Augmentive?
Key investors in Augmentive include Venrex Investment Management.
Will Augmentive IPO soon?
No public IPO plans have been announced for Augmentive.
How can I track Augmentive secondary market activity?
Caplight tracks bids, offers, and trades in Augmentive's shares on secondary markets.